Expertise in
3
conditions

Wouter J. Lansink

Ziekenhuis Oost Limburg
Genk, VLG, BE 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
3
conditions
Ziekenhuis Oost Limburg
Genk, VLG, BE 

Overview

Wouter Lansink practices practicing medicine in Genk, Belgium.

Lansink is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Peripheral Artery Disease, Atherosclerosis, and Angioplasty.

They are actively involved in clinical research, co-authoring 12 peer reviewed articles and participating in 9 clinical trials.

Locations

Ziekenhuis Oost Limburg
Genk, VLG, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

An RCT Evaluating the Safety and Efficacy of the Endovascular Treatment of Subjects with Stenotic or Restenotic Lesions of the Common Femoral Artery with the Supera Vascular Mimetic Implant Compared to Surgical Common Femoral Artery Endarterectomy
An RCT Evaluating the Safety and Efficacy of the Endovascular Treatment of Subjects with Stenotic or Restenotic Lesions of the Common Femoral Artery with the Supera Vascular Mimetic Implant Compared to Surgical Common Femoral Artery Endarterectomy
Enrollment Status: Recruiting
Publish Date: October 16, 2024
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Belgian Physician-initiated Trial Investigating the LifeStream Peripheral Stent Graft System for the Treatment of Complex TASC C and D Iliac Lesions
Belgian Physician-initiated Trial Investigating the LifeStream Peripheral Stent Graft System for the Treatment of Complex TASC C and D Iliac Lesions
Enrollment Status: Completed
Publish Date: March 05, 2026
Intervention Type: Device
Study Phase: Not Applicable
Belgian-Italian Prospective, Single Arm, Multicentre Study to Evaluate the Efficacy and Safety of BTK Treatment With the Luminor 14 Paclitaxel Coated Percutaneous Transluminal Angioplasty Balloon Catheter of iVascular of 150 Subjects With Critical Limb Ischemia
Belgian-Italian Prospective, Single Arm, Multicentre Study to Evaluate the Efficacy and Safety of BTK Treatment With the Luminor 14 Paclitaxel Coated Percutaneous Transluminal Angioplasty Balloon Catheter of iVascular of 150 Subjects With Critical Limb Ischemia
Enrollment Status: Completed
Publish Date: November 08, 2024
Intervention Type: Device
Study Phase: Not Applicable
Belgian Prospective, Non-randomized Multi-center, Controlled Physician-initiated Trial: Evaluation of the Safety and Efficacy of the ClearLumen II Peripheral Thrombectomy System Recanalization of Acute and Subacute Thrombotic Femoropopliteal Occlusions
Belgian Prospective, Non-randomized Multi-center, Controlled Physician-initiated Trial: Evaluation of the Safety and Efficacy of the ClearLumen II Peripheral Thrombectomy System Recanalization of Acute and Subacute Thrombotic Femoropopliteal Occlusions
Enrollment Status: Completed
Publish Date: October 16, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Randomized Controlled Non-inferiority Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of Subjects with Stenotic, Restenotic or Occlusive Lesions of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon
A Randomized Controlled Non-inferiority Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of Subjects with Stenotic, Restenotic or Occlusive Lesions of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon
Enrollment Status: Active_not_recruiting
Publish Date: October 16, 2024
Intervention Type: Device
Study Phase: Not Applicable
Market Penetration of Laser Therapy in Venous Surgery: ZOL - ZMK Center Experience
Market Penetration of Laser Therapy in Venous Surgery: ZOL - ZMK Center Experience
Enrollment Status: Completed
Publish Date: September 05, 2024
Intervention Type: Device
A Randomized Trial Comparing the Drug-Eluting Stent (DES) Below-the-Knee (BTK) Vascular Stent System (DES BTK Vascular Stent System) vs Percutaneous Transluminal Angioplasty (PTA) Treating Infrapopliteal Lesions in Subjects With Critical Limb Ischemia
A Randomized Trial Comparing the Drug-Eluting Stent (DES) Below-the-Knee (BTK) Vascular Stent System (DES BTK Vascular Stent System) vs Percutaneous Transluminal Angioplasty (PTA) Treating Infrapopliteal Lesions in Subjects With Critical Limb Ischemia
Enrollment Status: Completed
Publish Date: July 01, 2024
Intervention Type: Combination product, Device
Study Phase: Phase 3
BIOTRONIK - A Prospective, International, Multi-centre, Post-market All-comers Registry to Assess the Clinical Performance of the Passeo-18 Lux Paclitaxel Releasing Balloon Catheter in Popliteal Arteries - III BENELUX
BIOTRONIK - A Prospective, International, Multi-centre, Post-market All-comers Registry to Assess the Clinical Performance of the Passeo-18 Lux Paclitaxel Releasing Balloon Catheter in Popliteal Arteries - III BENELUX
Enrollment Status: Completed
Publish Date: August 15, 2022
Intervention Type: Device
A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Comparing the Lutonix Drug Coated Balloon Versus Standard Balloon Angioplasty for Treatment of Below-the-Knee (BTK) Arteries(Lutonix BTK Trial)
A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Comparing the Lutonix Drug Coated Balloon Versus Standard Balloon Angioplasty for Treatment of Below-the-Knee (BTK) Arteries(Lutonix BTK Trial)
Enrollment Status: Completed
Publish Date: February 09, 2022
Intervention Type: Device
Study Phase: Not Applicable
View 8 Less Clinical Trials

12 Total Publications

Head-to-head comparison of two paclitaxel-coated balloons for femoropopliteal lesions: 3-year results from the BIOPACT RCT.
Head-to-head comparison of two paclitaxel-coated balloons for femoropopliteal lesions: 3-year results from the BIOPACT RCT.
Journal: The Journal of cardiovascular surgery
Published: December 23, 2025

Frequently Asked Questions about Wouter J. Lansink

Is Wouter J. Lansink a top-rated expert for Peripheral Artery Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Wouter J. Lansink is classified as an Advanced expert for Peripheral Artery Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Wouter J. Lansink participate in research or clinical trials?

Yes. Wouter J. Lansink has published 12 articles and abstracts on conditions like Peripheral Artery Disease. You can view a list of Wouter J. Lansink's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Lansink's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile